MoneyWorks4Me

Sequent Scientific - Quaterly Results

23 May 2023 Evaluate
The sales declined to Rs. 465.95 millions for the March 2023 quarter as compared to Rs. 636.73 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2023 is Rs. -16.45 millions as compared to Net Profit of Rs. 66.48 millions of corresponding quarter ended March 2022Operating profit for the quarter ended March 2023 decreased to 19.68 millions as compared to 109.86 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 465.95 636.73 -26.82 2226.85 2196.26 1.39 2226.85 2196.26 1.39
Other Income 80.13 57.72 38.83 282.42 276.43 2.17 282.42 276.43 2.17
PBIDT 19.68 109.86 -82.09 18.82 268.93 -93.00 18.82 268.93 -93.00
Interest 8.67 6.08 42.60 25.13 16.10 56.09 25.13 16.10 56.09
PBDT 11.01 103.78 -89.39 -6.31 252.83 -102.50 -6.31 252.83 -102.50
Depreciation 23.31 23.41 -0.43 91.15 95.93 -4.98 91.15 95.93 -4.98
PBT -12.30 80.37 -115.30 -97.46 156.90 -162.12 -97.46 156.90 -162.12
TAX 4.15 13.89 -70.12 -36.66 8.91 -511.45 -36.66 8.91 -511.45
Deferred Tax -3.64 3.04 -219.74 -30.94 5.20 -695.00 -30.94 5.20 -695.00
PAT -16.45 66.48 -124.74 -60.80 147.99 -141.08 -60.80 147.99 -141.08
Equity 498.87 496.74 0.43 498.87 496.74 0.43 498.87 496.74 0.43
PBIDTM(%) 4.22 17.25 -75.52 0.85 12.24 -93.10 0.85 12.24 -93.10
Peers
Company Name CMP
Sun Pharma. Inds. 1846.20
Dr. Reddys Labs. 1208.25
Cipla 1367.10
Lupin 2114.70
Zydus Lifesciences 1163.85
View more..